Aggressive transformation of juvenile myelomonocytic leukemia associated with duplication of oncogenic KRAS due to acquired uniparental disomy

Journal of Pediatrics

Volumn 162, Issue 6, 2013, Pages

  Kato, Motohiro ^a   Yasui, Naoko ^a   Seki, Masafumi ^b   Kishimoto, Hiroshi ^a   Sato Otsubo, Aiko ^b   Hasegawa, Daisuke ^c   Kiyokawa, Nobutaka ^d   Hanada, Ryoji ^a   Ogawa, Seishi ^b   Manabe, Atsushi ^c   Takita, Junko ^b   Koh, Katsuyoshi ^a  

^a SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

^d Department of Pediatric Hematology and Oncology Research ^*  (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MERCAPTOPURINE;

ARTICLE; AUTOPSY; BONE MARROW BIOPSY; CANCER GROWTH; CASE REPORT; CHILD; CONSCIOUSNESS DISORDER; GENE DUPLICATION; GENE MUTATION; HEPATOSPLENOMEGALY; HUMAN; HUMAN TISSUE; JUVENILE MYELOMONOCYTIC LEUKEMIA; KARYOTYPING; MALE; MALIGNANT TRANSFORMATION; MOSAICISM; ONCOGENE K RAS; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TACHYPNEA; UNIPARENTAL DISOMY;

EID: 84880573567     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2013.01.003     Document Type: Article

References (15)

1. Loh ML. Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemia. Br J Haematol 2011;152:677-87.
2. Niemeyer CM, Arico M, Basso G, Biondi A, Cantu Rajnoldi A, Creutzig U, et al., European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS). Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. Blood 1997;89: 3534-43.
3. Luna-Fineman S, Shannon KM, Atwater SK, Davis J, Masterson M, Ortega J, et al. Myelodysplastic and myeloproliferative disorders of childhood: a study of 167 patients. Blood 1999;93:459-66.
4. Chan RJ, Cooper T, Kratz CP, Weiss B, Loh ML. Juvenile myelomonocytic leukemia: a report from the 2nd International JMML Symposium. Leuk Res 2009;33:355-62.
5. Nannya Y, Sanada M, Nakazaki K, Hosoya N, Wang L, Hangaishi A, et al. A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. Cancer Res 2005;65:6071-9.
6. Yamamoto G, Nannya Y, Kato M, Sanada M, Levine RL, Kawamata N, et al. Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of Affymetrix single-nucleotide polymorphism genotyping microarrays. Am J Hum Genet 2007;81:114-26.
7. Matsuda K, Nakazawa Y, Sakashita K, Shiohara M, Yamauchi K, Koike K. Acquisition of loss of the wild-type NRAS locus with aggressive disease progression in a patient with juvenile myelomonocytic leukemia and a heterozygous NRAS mutation. Haematologica 2007;92:1576-8.
8. Zhang Z, Wang Y, Vikis HG, Johnson L, Liu G, Li J, et al. Wildtype Kras2 can inhibit lung carcinogenesis in mice. Nat Genet 2001;29:25-33.
9. Dunbar AJ, Gondek LP, O'Keefe CL, Makishima H, Rataul MS, Szpurka H, et al. 250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies. Cancer Res 2008;68:10349-57.
10. Wang J, Liu Y, Li Z, Du J, Ryu MJ, Taylor PR, et al. Endogenous oncogenic Nras mutation promotes aberrant GM-CSF signaling in granulocytic/monocytic precursors in a murine model of chronic myelomonocytic leukemia. Blood 2010;116:5991-6002.
11. Sanada M, Suzuki T, Shih LY, Otsu M, Kato M, Yamazaki S, et al. Gainof- function of mutated C-CBL tumour suppressor in myeloid neoplasms. Nature 2009;460:904-8.
12. Schmiegelow K, Al-Modhwahi I, Andersen MK, Behrendtz M, Forestier E, Hasle H, et al. Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study. Blood 2009;113:6077-84.
13. Olk-Batz C, Poetsch AR, Nollke P, Claus R, Zucknick M, Sandrock I, et al. Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome. Blood 2011;117:4871-80.
14. Doisaki S, Muramatsu H, Shimada A, Takahashi Y, Mori-Ezaki M, Sato M, et al. Somatic mosaicism for oncogenic NRAS mutations in juvenile myelomonocytic leukemia. Blood 2012;120:1485-8.
15. Matsuda K, Shimada A, Yoshida N, Ogawa A, Watanabe A, Yajima S, et al. Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomonocytic leukemia with specific RAS mutations. Blood 2007;109:5477-80.